Onassis Holdings Retained Investment Bank Dalmore Group to Launch up to $75 Million Regulation A+ Offering (Mini IPO)

Dalmore Group’s deals have exceeded $9B since 2021 NEW YORK, May 24, 2023 /PRNewswire/ — Onassis Holding Corp (OTC: ONSS), a wellness and biotech focused holding company, announced the launch of a Regulation A+ financing round. This follows an agreement with Dalmore Group in 2022. Reg A+ provides a streamlined process for companies to raise up … Read more

UFC GYM® and UFC FIT® Celebrates Continued Expansion as the Brand Brings Purpose to Fitness, Offering a Unique Value Proposition That Goes Beyond Traditional Gym Memberships

NEWPORT BEACH, Calif., May 24, 2023 /PRNewswire/ — UFC GYM®, the first major brand extension of UFC®, today announced the sale of three new franchise locations, expanding the fast-growing brand’s nationwide footprint. With more than 900 locations in 40 countries currently in development, the new locations add to the organization’s vision to provide a wholistic … Read more

BlueSprig Pediatrics to Introduce Attend Behavior App for Caregivers of Children with Autism

HOUSTON, May 24, 2023 /PRNewswire/ — BlueSprig Pediatrics, one of the largest autism therapy providers in the United States, announced today the launch of the Attend Behavior app for all families served across its more than 140 locations. Attend Behavior is a mobile technology solution that provides caregivers of children with autism, ADHD, and other types … Read more

Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

Only ready-to-use (RTU) liquid format of bivalirudin expected to begin shipping in summer 2023 RTU bivalirudin injection does not require reconstitution, dilution or mixing, which helps increase efficiency for hospitals and healthcare providers DUBLIN, May 24, 2023 /PRNewswire/ — Endo International plc (OTC: ENDPQ) announced today that its subsidiary Endo Ventures Limited has executed an agreement … Read more

Phio Pharmaceuticals Announces Initiation of Collaborative Clinical Trial with PH-762, AgonOx’s Tumor Infiltrating Lymphocyte Program (AGX148) and Providence Cancer Institute

One of two newly announced clinical trials for its lead product candidate, PH-762 MARLBOROUGH, Mass., May 24, 2023 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today announced its clinical development partner, AgonOx, … Read more

ATI ADVISORY NOW A PACE TECHNICAL ASSISTANCE CENTER

WASHINGTON, May 24, 2023 /PRNewswire/ — ATI Advisory (ATI) announces new capabilities to support growth in the Program of All-Inclusive Care for the Elderly (PACE). The National PACE Association (NPA) has added ATI Advisory to its list of approved Technical Assistance Centers (TACs) who offer full capabilities to guide and assist organizations developing and expanding … Read more

Lavie Bio Receives Canadian Regulatory Approval for Thrivus™, Expanding Global Reach

“Our product has played a key role in boosting farmers’ yields and promoting more sustainable food production practices,” commented Mr. Amit Noam, CEO of Lavie Bio. “We are currently seeing high demand in our market in the USA, and gaining regulatory approval from Canada is a significant milestone for our global expansion plan. This year … Read more

Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability

New financing led by Vensana Capital to support commercial expansion and launch of new surgical solutions for joint instability  MARIETTA, Ga., May 24, 2023 /PRNewswire/ — Artelon Inc., a privately held medical device company, announced today that it closed approximately $20 million in Series B funding, led by Vensana Capital with expected additional participation from … Read more

Institute of Oncology Ljubljana Leverages SOPHiA DDM™ Platform for Cancer Research

SOPHiA DDM™ deep-learning algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers BOSTON and LAUSANNE, Switzerland, May 24, 2023 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the Institute of Oncology Ljubljana (IOL), a comprehensive public institution for … Read more

Head and Neck Cancer Market Worth US$ 5.0 billion by 2032, with a CAGR of 12.9% during the Forecast Period

According To Prophecy Market Insights “Head and Neck Cancer Market accounted for US$ 1.4 billion in 2022 and is estimated to be US$ 5.0 billion by 2032 and is anticipated to register a CAGR of 12.9%” COVINA, Calif., May 24, 2023 /PRNewswire/ — What is Overview of Head and Neck Cancer Market? Cancer is the type … Read more